Literature DB >> 3742466

The significance of the fibrin/fibrinogen degradation product in serum of carcinoma patients with hematogenous metastasis.

S Imaoka, Y Sasaki, T Iwanaga, T Terasawa.   

Abstract

Fibrin/fibrinogen degradation product (FDP) was measured in 270 cases with various carcinomas. An elevation of FDP (5 micrograms/ml or more) was observed in 68 cases (25%). Of the 68 elevated FDP cases, 5 (82%) were inoperable or received nonradical resection. Forty of those 56 cases (71%) showed hematogenous metastasis. FDP in those cases which showed hematogenous metastasis was found to be due to fibrinolysis accompanied by consumption coagulopathy.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3742466     DOI： 10.1002/1097-0142(19861001)58:7<1488::aid-cncr2820580719>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Malignant gastrointestinal stromal tumor of the small intestine: rare complication of acute disseminated intravascular coagulation without hematogenous metastasis.

Authors:  M Nishimura; A Komori; M Matsushita; A Fukutani; Y Fujiyama; T Bamba
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

3.  FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS IN MALIGNANCY.

Authors:  Ramji Rai; Brig Skbasu; M P Jaiprakash
Journal:  Med J Armed Forces India       Date:  2017-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.